Bayesian Nonparametric Cost-Effectiveness Analyses: Causal Estimation and Adaptive Subgroup Discovery

• URL: http://arxiv.org/abs/2002.04706v2
• Date: Tue, 8 Sep 2020 22:28:22 GMT
• Title: Bayesian Nonparametric Cost-Effectiveness Analyses: Causal Estimation and Adaptive Subgroup Discovery
• Authors: Arman Oganisian, Nandita Mitra, Jason Roy
• Abstract summary: We develop a nonparametric Bayesian model for joint cost-survival distributions in the presence of censoring. We use our model to assess the cost-efficacy of endometrial chemotherapy versus radiation adjuvant therapy for treating cancer in the SEER-Medicare database.
• Score: 0.0
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Cost-effectiveness analyses (CEAs) are at the center of health economic decision making. While these analyses help policy analysts and economists determine coverage, inform policy, and guide resource allocation, they are statistically challenging for several reasons. Cost and effectiveness are correlated and follow complex joint distributions which are difficult to capture parametrically. Effectiveness (often measured as increased survival time) and accumulated cost tends to be right-censored in many applications. Moreover, CEAs are often conducted using observational data with non-random treatment assignment. Policy-relevant causal estimation therefore requires robust confounding control. Finally, current CEA methods do not address cost-effectiveness heterogeneity in a principled way - often presenting population-averaged estimates even though significant effect heterogeneity may exist. Motivated by these challenges, we develop a nonparametric Bayesian model for joint cost-survival distributions in the presence of censoring. Our approach utilizes a joint Enriched Dirichlet Process prior on the covariate effects of cost and survival time, while using a Gamma Process prior on the baseline survival time hazard. Causal CEA estimands, with policy-relevant interpretations, are identified and estimated via a Bayesian nonparametric g-computation procedure. Finally, we outline how the induced clustering of the Enriched Dirichlet Process can be used to adaptively detect presence of subgroups with different cost-effectiveness profiles. We outline an MCMC procedure for full posterior inference and evaluate frequentist properties via simulations. We use our model to assess the cost-efficacy of chemotherapy versus radiation adjuvant therapy for treating endometrial cancer in the SEER-Medicare database.

Related papers

• Targeted Machine Learning for Average Causal Effect Estimation Using the Front-Door Functional [3.0232957374216953]
  evaluating the average causal effect (ACE) of a treatment on an outcome often involves overcoming the challenges posed by confounding factors in observational studies. Here, we introduce novel estimation strategies for the front-door criterion based on the targeted minimum loss-based estimation theory. We demonstrate the applicability of these estimators to analyze the effect of early stage academic performance on future yearly income.
  arXiv  Detail & Related papers  (2023-12-15T22:04:53Z)
• Improved Policy Evaluation for Randomized Trials of Algorithmic Resource Allocation [54.72195809248172]
  We present a new estimator leveraging our proposed novel concept, that involves retrospective reshuffling of participants across experimental arms at the end of an RCT. We prove theoretically that such an estimator is more accurate than common estimators based on sample means.
  arXiv  Detail & Related papers  (2023-02-06T05:17:22Z)
• Robust and Agnostic Learning of Conditional Distributional Treatment Effects [62.44901952244514]
  The conditional average treatment effect (CATE) is the best point prediction of individual causal effects. In aggregate analyses, this is usually addressed by measuring distributional treatment effect (DTE) We provide a new robust and model-agnostic methodology for learning the conditional DTE (CDTE) for a wide class of problems.
  arXiv  Detail & Related papers  (2022-05-23T17:40:31Z)
• Partial Identification of Dose Responses with Hidden Confounders [25.468473751289036]
  Inferring causal effects of continuous-valued treatments from observational data is a crucial task. We present novel methodology to bound both average and conditional average continuous-valued treatment-effect estimates. We apply our method to a real-world observational case study to demonstrate the value of identifying dose-dependent causal effects.
  arXiv  Detail & Related papers  (2022-04-24T07:02:21Z)
• An Efficient Approach for Optimizing the Cost-effective Individualized Treatment Rule Using Conditional Random Forest [5.406112598028401]
  We use the concept of net-monetary-benefit (NMB) to assess the trade-off between health benefits and related costs. We identify the optimal CE-ITR using NMB-based classification algorithms. We apply our top-performing algorithm to the NIH-funded Systolic Blood Pressure Intervention Trial.
  arXiv  Detail & Related papers  (2022-04-23T01:36:24Z)
• Reinforcement Learning with Heterogeneous Data: Estimation and Inference [84.72174994749305]
  We introduce the K-Heterogeneous Markov Decision Process (K-Hetero MDP) to address sequential decision problems with population heterogeneity. We propose the Auto-Clustered Policy Evaluation (ACPE) for estimating the value of a given policy, and the Auto-Clustered Policy Iteration (ACPI) for estimating the optimal policy in a given policy class. We present simulations to support our theoretical findings, and we conduct an empirical study on the standard MIMIC-III dataset.
  arXiv  Detail & Related papers  (2022-01-31T20:58:47Z)
• Assessment of Treatment Effect Estimators for Heavy-Tailed Data [70.72363097550483]
  A central obstacle in the objective assessment of treatment effect (TE) estimators in randomized control trials (RCTs) is the lack of ground truth (or validation set) to test their performance. We provide a novel cross-validation-like methodology to address this challenge. We evaluate our methodology across 709 RCTs implemented in the Amazon supply chain.
  arXiv  Detail & Related papers  (2021-12-14T17:53:01Z)
• COVI-AgentSim: an Agent-based Model for Evaluating Methods of Digital Contact Tracing [68.68882022019272]
  COVI-AgentSim is an agent-based compartmental simulator based on virology, disease progression, social contact networks, and mobility patterns. We use COVI-AgentSim to perform cost-adjusted analyses comparing no DCT to: 1) standard binary contact tracing (BCT) that assigns binary recommendations based on binary test results; and 2) a rule-based method for feature-based contact tracing (FCT) that assigns a graded level of recommendation based on diverse individual features.
  arXiv  Detail & Related papers  (2020-10-30T00:47:01Z)
• Estimating heterogeneous survival treatment effect in observational data using machine learning [9.951103976634407]
  Methods for estimating heterogeneous treatment effect in observational data have largely focused on continuous or binary outcomes. Using flexible machine learning methods in the counterfactual framework is a promising approach to address challenges due to complex individual characteristics.
  arXiv  Detail & Related papers  (2020-08-17T01:02:14Z)
• Enabling Counterfactual Survival Analysis with Balanced Representations [64.17342727357618]
  Survival data are frequently encountered across diverse medical applications, i.e., drug development, risk profiling, and clinical trials. We propose a theoretically grounded unified framework for counterfactual inference applicable to survival outcomes.
  arXiv  Detail & Related papers  (2020-06-14T01:15:00Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.